Global X Genomics & Biotechnology ETF
GNOM
63 hedge funds and large institutions have $128M invested in Global X Genomics & Biotechnology ETF in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
11% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 18
0% more funds holding
Funds holding: 63 → 63 (0)
0.42% less ownership
Funds ownership: 16.84% → 16.41% (-0.42%)
8% less capital invested
Capital invested by funds: $138M → $128M (-$10.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OCM
One Capital Management
Westlake Village,
California
|
+$665K |
| 2 |
Rockefeller Capital Management
New York
|
+$370K |
| 3 |
MWAM
Manhattan West Asset Management
Los Angeles,
California
|
+$349K |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$227K |
| 5 |
IWM
IHT Wealth Management
Chicago,
Illinois
|
+$134K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$8.05M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$762K |
| 3 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$479K |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$435K |
| 5 |
IA
Insight Advisors
Newtown,
Pennsylvania
|
-$264K |
GNOM Hedge Fund Activity: Q2 2023 in Review
63 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q2 2023, worth a combined $128M — down 7.5% from $138M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new GNOM positions and 4 closed out — a net gain of 1 holder — while 20 added to existing stakes and 18 trimmed.
The largest buyer was One Capital Management, adding an estimated $665K. The largest seller was Northwestern Mutual Wealth Management, cutting an estimated $8.05M.
- 63 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $128M of Global X Genomics & Biotechnology ETF stock for Q2 2023, down 7.5% quarter-over-quarter.
- 5 funds opened new Global X Genomics & Biotechnology ETF positions in Q2 2023 and 4 closed out, a net change of +1 holder.
- The largest Global X Genomics & Biotechnology ETF buyer in Q2 2023 was One Capital Management, an estimated $665K added.
- The largest Global X Genomics & Biotechnology ETF seller in Q2 2023 was Northwestern Mutual Wealth Management, an estimated $8.05M sold.
Based on aggregated 13F filings for Q2 2023.